Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

A nationwide prospective clinical trial on active surveillance in patients with non-intra-abdominal desmoid-type fibromatosis; the Grafiti trial

2022; Elsevier BV; Volume: 48; Issue: 2 Linguagem: Inglês

10.1016/j.ejso.2021.12.413

ISSN

1532-2157

Autores

Anne‐Rose W. Schut, Milea J. M. Timbergen, Danique van Broekhoven, Thijs van Dalen, Winan J. van Houdt, Frits van Coevorden, Johannes J. Bonenkamp, Sander D. Dijkstra, Marc H.A. Bemelmans, Lukas B. Been, Robert van Ginkel, Stefan Sleijfer, Dirk J. Grünhagen, Cornelis Verhoef,

Tópico(s)

Soft tissue tumors and treatment

Resumo

Background: Desmoid-type fibromatosis (DTF) has a highly variable clinical course, displaying phases of progressive growth, stabilization or even spontaneous regression without treatment. Active surveillance (AS) is currently recommended as primary treatment. The aim of this study was to assess tumour behaviour and the efficacy of AS in DTF patients.

Referência(s)